Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Try the new Yahoo Finance
Advertisement
U.S. Markets open in 2 hrs 41 mins
S&P Futures
5,866.75
-29.50
(-0.50%)
Dow Futures
42,985.00
-192.00
(-0.44%)
Nasdaq Futures
20,391.00
-128.50
(-0.63%)
Russell 2000 Futures
2,237.90
-17.60
(-0.78%)
Crude Oil
71.22
+0.66
(+0.94%)
Gold
2,752.50
+13.60
(+0.50%)
Emergent BioSolutions Inc. (EBS)
NYSE - Nasdaq Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
10.18
+0.83
(+8.88%)
At close: 04:00PM EDT
10.30
+0.12
(+1.18%)
Pre-Market:
06:33AM EDT
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
Expand All
All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,074,400
1,023,000
1,076,100
1,639,400
1,462,200
Cost of Revenue
802,600
705,400
693,100
748,100
537,000
Gross Profit
271,800
317,600
383,000
891,300
925,200
Operating Expense
476,000
519,100
546,300
508,200
486,700
Operating Income
-204,200
-201,500
-163,300
383,100
438,500
Net Non Operating Interest Income Expense
-89,300
-87,900
-37,300
-34,500
-31,300
Other Income Expense
-284,600
-441,800
-18,400
-45,400
4,700
Pretax Income
-578,100
-731,200
-219,000
303,200
411,900
Tax Provision
8,900
29,300
-7,400
83,700
106,100
Net Income Common Stockholders
-587,000
-760,500
-211,600
219,500
305,800
Diluted NI Available to Com Stockholders
-587,000
-760,500
-211,600
219,500
305,800
Basic EPS
-15.56
-14.85
-4.47
4.32
5.79
Diluted EPS
-15.56
-14.85
-4.47
4.27
5.67
Basic Average Shares
50,625
51,200
50,100
53,500
52,700
Diluted Average Shares
50,625
51,200
50,100
54,100
53,800
Total Operating Income as Reported
-449,600
-726,400
-170,000
341,400
438,500
Total Expenses
1,278,600
1,224,500
1,239,400
1,256,300
1,023,700
Net Income from Continuing & Discontinued Operation
-587,000
-760,500
-211,600
219,500
305,800
Normalized Income
-360,981
-404,447
-205,101
249,524
305,800
Interest Expense
89,300
87,900
37,300
34,500
31,300
Net Interest Income
-89,300
-87,900
-37,300
-34,500
-31,300
EBIT
-488,800
-643,300
-181,700
337,700
443,200
EBITDA
-374,800
-518,200
-38,400
461,500
557,700
Reconciled Cost of Revenue
753,600
645,900
609,700
682,800
482,300
Reconciled Depreciation
114,000
125,100
143,300
123,800
114,500
Net Income from Continuing Operation Net Minority Interest
-587,000
-760,500
-211,600
219,500
305,800
Total Unusual Items Excluding Goodwill
-286,100
-450,700
-6,700
-41,700
0
Total Unusual Items
-286,100
-450,700
-6,700
-41,700
0
Normalized EBITDA
-88,700
-67,500
-31,700
503,200
557,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-60,081
-94,647
-201
-11,676
0
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy controls
WA Consumer Health Privacy Policy
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.